Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins 'Money Movers' to discuss Jorgensen's comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...

A day after the warning landed on semaglutide labels, Novo Nordisk CEO Lars Fruergaard Jørgensen said he is alarmed by the amount of unsafe compounded GLP-1s in the U.S. market, adding that the ...

Stepping into this turbulent environment is Novo Nordisk’s new CEO Lars Fruergaard Jørgensen. A 25-year insider at Novo Nordisk, Jørgensen took the helm in January this year, and brought in ...

After the 2024 U.S. election, Vermont Senator Bernie Sanders delivered a sharp critique of the Democratic party, asserting ...

Bruger milliarder på ekstremist Bernie Sanders mener slet og ret, at den siddende administration har mistet befolkningens opbakning. Det har den, blandt andet, fordi den bruger milliarder af dollars ...

Novo Nordisk has shaken off fears of a drug pricing crackdown from president Donald Trump, after it beat profit forecasts in Q1 results. Trump had been expected to launch measures to crackdown on ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...